The IPO Buzz: CG Oncology (CGON) Scores a NASDAQ Moonshot
CG Oncology (CGON) – the first biotech IPO of the year – scored a moonshot today in its NASDAQ debut. The bladder cancer biotech doubled its $19.00 IPO price – rising to $38.00 shortly after 3 p.m. EST today (Thursday, Jan. 25, 2024). A moonshot occurs when a company doubles its IPO stock price – […]
January 25, 2024 Read More